Workflow
DMG Blockchain Solutions Announces Asset Purchase to Establish its First US-based Data Center, October Preliminary Operational Results
Globenewswire· 2025-11-04 07:59
DMG Blockchain Solutions Announces Asset Purchase to Establish its First US-based Data Center; October Preliminary Operational Results Asset Purchase to Establish its First US-based Data Center; October Preliminary Operational Results VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) ("DMG"), a leading vertically integrated blockchain and data center technology company, announces it has signed a letter agreement ...
Baiyun Airport's Terminal 3 Becomes Operational, Inaugural Flight Operated by C919
Globenewswire· 2025-11-04 07:49
Core Insights - The commissioning of Terminal 3 at Guangzhou Baiyun International Airport marks a significant milestone, enhancing the airport's operational capacity to "five runways and three terminals" and supporting Guangzhou's ambition to become a major international aviation hub [1][9]. Infrastructure Development - Terminal 3 features a design inspired by local characteristics, resembling a blooming flower, and integrates smart technology with human-centric design to improve passenger experience [6][8]. - The terminal includes 199 check-in counters, 60 self-service kiosks, 59 baggage drop units, and 31 domestic and 9 international security lanes, enhancing operational efficiency [7]. Technological Advancements - Terminal 3 is the first large-scale hub airport terminal in China to fully implement Building Information Modeling (BIM) for smart construction, setting a new industry standard [8]. - It is also the first terminal in China to achieve paperless archives, storing all building information electronically for better future management [8]. Operational Capacity and Connectivity - The expansion from "two runways and one terminal" to "five runways and three terminals" significantly boosts Baiyun Airport's hub capacity, attracting more airlines and increasing flight frequencies [9]. - Since the beginning of the year, over 30 international passenger routes have been launched or resumed, enhancing the airport's role as a core node of the "Air Silk Road" [10]. Future Development - Baiyun Airport aims to leverage the opening of Terminal 3 to foster synergistic development within the Guangdong-Hong Kong-Macao Greater Bay Area, striving to become a benchmark for high-quality development in China's civil aviation sector [11].
Ayvens repurchases EUR 275 million of own shares in Lincoln Consortium’s sell down
Globenewswire· 2025-11-04 07:46
Core Viewpoint - Ayvens has initiated a share buyback program, repurchasing EUR 275 million of its shares, which is part of a larger sell-down by the Lincoln Consortium totaling approximately EUR 940 million [1]. Group 1: Share Buyback Program - The share buyback program was announced on 30 October 2025, with the repurchased shares amounting to 3.1% of the Group's share capital and representing 76% of the total EUR 360 million allocated for the buyback [1]. - The shares bought back will be cancelled as authorized by Ayvens' combined General Shareholders' Meeting on 19 May 2025 [2]. Group 2: Company Overview - Ayvens is a leading global player in sustainable mobility, providing services such as full-service leasing, flexible subscription services, fleet management, and multi-mobility solutions [3]. - The company operates with over 14,000 employees across 41 countries and is positioned to lead the transition to net zero while driving digital transformation in the mobility sector [4][5]. - Ayvens is listed on Compartment A of Euronext Paris, with Societe Generale Group as its majority shareholder [4].
Third Quarter Report 2025
Globenewswire· 2025-11-04 07:45
Core Insights - The company experienced a significant improvement in customer activity starting in August, leading to a notable increase in net sales to 7.8 MSEK in Q3 from 4.6 MSEK in Q2 [3] - The uncertainty surrounding potential tariffs had a detrimental effect on the industry, causing delays in procurement cycles and tender awards during the first half of the year [4] - A positive trend in order intake has been observed since August, indicating stronger performance in the second half of 2025 compared to the first half [5] Financial Performance - For Q3, net sales amounted to 7,765 KSEK, an increase from 3,392 KSEK in the previous year [8] - EBITDA for Q3 was -4,283 KSEK, an improvement from -6,657 KSEK in the same quarter last year [8] - Cash flow from operating activities in Q3 was -7,783 KSEK, compared to -3,623 KSEK in the previous year [8] Operational Developments - The company has completed its recruitment for the year, doubling its sales organization from four to eight members, which is expected to enhance lead generation and partner onboarding [6] - In-house production commenced in Lund, successfully manufacturing the first five instruments, contributing to improved product quality and cost efficiency [7] - The establishment of local assembly capabilities in key markets is anticipated to provide strategic advantages in the future [7] Market Outlook - With a fully staffed organization and operational capabilities in place, the company is positioned for renewed and sustainable growth, entering the final quarter of the year with strong momentum [8] - The normalization of the market since August is expected to lead to increased tender issuance and improved order intake [5]
Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia
Globenewswire· 2025-11-04 07:45
Core Insights - Modus Therapeutics has received regulatory approval to initiate the second part of its phase 2 study for sevuparin, targeting chronic kidney disease with anemia, set to begin in Q4 2025 [1][2][3] Company Overview - Karolinska Development AB holds a 54% direct and 1% indirect ownership in Modus Therapeutics, indicating a significant stake in the company's progress [3] - The company focuses on identifying and investing in breakthrough medical innovations in the Nordic region, aiming to develop these into commercial products that improve patient lives while providing returns to shareholders [4][5] Clinical Development - The second part of the clinical study will evaluate three doses of sevuparin, building on initial data that demonstrated the drug's good tolerance [2] - The approval is seen as a crucial milestone for Modus Therapeutics, allowing it to adhere to its planned clinical development timeline [3]
Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locations
Globenewswire· 2025-11-04 07:39
Core Insights - Temenos has been certified as a Great Place to Work in 15 locations globally in 2025, expanding from 10 countries earlier this year [1][2] - The certification reflects positive employee feedback, indicating a strong workplace culture and employee experience [2][3] Company Expansion and Recognition - The recent certification includes five new locations: United States, India, Ecuador, Hong Kong, and Taiwan [1] - In the US, the recognition follows the strategic expansion of Temenos' workforce and the establishment of an Innovation Hub in Central Florida [3] Employee Engagement and Culture - Temenos emphasizes a culture of empowerment and accountability, which is crucial for its success [3] - The company has been recognized in India for the second consecutive year, highlighting its investment in local culture and employee engagement [4] Employee Experience Initiatives - Temenos prioritizes employee experience through flexible working policies, inclusive leadership programs, and a focus on diversity and wellbeing [5] - These initiatives contribute to a supportive environment where employees feel valued and inspired [5] Job Market Insights - Research indicates that job seekers are significantly more likely to find great management and experience job satisfaction at Great Place to Work-certified companies [6]
AS Tallink Grupp Statistics for October 2025
Globenewswire· 2025-11-04 07:00
In October 2025, AS Tallink Grupp transported 467,279 passengers, which is a 2.5% decrease compared to October 2024. The number of cargo units decreased by 10.2% to 21,855 units and the number of passenger vehicles decreased by 2.6% to 58,006 units compared to the same period a year ago. AS Tallink Grupp passenger, cargo unit and passenger vehicle numbers for October 2025 were the following: October 2025October 2024ChangePassengers467,279479,232-2.5%Finland - Sweden137,011135,1191.4%Estonia - Finland286,55 ...
Eurocastle announces Director resignation
Globenewswire· 2025-11-04 07:00
EUROCASTLE INVESTMENT LIMITED FOR IMMEDIATE RELEASEContact: Oak Fund Services (Guernsey) LimitedCompany AdministratorAttn: Nicole BarnesTel: +44 1481 752957 Eurocastle Announces Resignation of Mr. Constantine (Dean) Dakolias from Board of Directors Guernsey, 4 November 2025 – Eurocastle Investment Limited (Euronext Amsterdam: ECT) today announces that Mr. Constantine (Dean) Dakolias retired as a non-independent director of the Company, effective 3 November 2025. The Board extends its sincere gratitude f ...
Equinor ASA: Share buy-back – fourth tranche for 2025
Globenewswire· 2025-11-04 07:00
Please see below information about transactions made under the fourth tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the buy-back tranche was announced: 29 October 2025. The duration of the buy-back tranche: 30 October to no later than 2 February 2026. Further information on the tranche can be found in the stock market announcement on its commencement dated 29 October 2025, available here: https://newsweb.oslobors.no/message/658157 F ...
Elis: Disclosure of trading in own shares occured from October 28 to October 31, 2025
Globenewswire· 2025-11-04 07:00
Disclosure of trading in own shares occurred from October 28 to October 31, 2025 Saint-Cloud, November 4, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from October 28 to October 31, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction da ...